We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EPWR
1801
DELISTED
Empowerment & Inclusion Capital I Corp.
EPWR
$978K ﹤0.01%
99,992
– –
EPWR.WS
1802
CALL
DELISTED
Empowerment & Inclusion Capital I Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
EPWR.WS
$978K ﹤0.01%
99,996
+50,000
+100% +$28.1K
GRCL
1803
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$976K ﹤0.01%
75,034
-25,399
-25% -$340K
HMCO
1804
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
$975K ﹤0.01%
99,990
– –
FSRX
1805
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
$970K ﹤0.01%
+99,984
New +$980K
PAQCW
1806
CALL
DELISTED
Provident Acquisition Corp. Warrant
PAQCW
$970K ﹤0.01%
99,997
-22,464
-18% -$17.9K
EMN icon
1807
Eastman Chemical
EMN
$7.79B
$969K ﹤0.01%
8,299
-52,602
-86% -$6.32M
BIOTW
1808
CALL
DELISTED
Biotech Acquisition Company Warrant
BIOTW
$967K ﹤0.01%
99,993
+50,000
+100% +$34.8K
BIOT
1809
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
$967K ﹤0.01%
99,986
– –
MPC icon
1810
Marathon Petroleum
MPC
$89.3B
$966K ﹤0.01%
15,996
+15,895
+15,738% +$932K
AEON.WS
1811
CALL
DELISTED
AEON Biopharma Inc
AEON.WS
$966K ﹤0.01%
+100,330
New +$76.2K
HCCC
1812
DELISTED
Healthcare Capital Corp. Class A common stock
HCCC
$965K ﹤0.01%
99,990
– –
HCCCW
1813
CALL
DELISTED
Healthcare Capital Corp. Warrant
HCCCW
$965K ﹤0.01%
99,995
+50,000
+100% +$33K
AMSF icon
1814
AMERISAFE
AMSF
$573M
$964K ﹤0.01%
+16,150
New +$1.03M
EEFT icon
1815
Euronet Worldwide
EEFT
$3.15B
$963K ﹤0.01%
7,116
-3,977
-36% -$580K
ITQ
1816
DELISTED
Itiquira Acquisition Corp. Class A Ordinary Shares
ITQ
$963K ﹤0.01%
+99,994
New +$970K
ARCE
1817
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$961K ﹤0.01%
31,331
-150,126
-83% -$4.28M
NDACW
1818
CALL
DELISTED
NightDragon Acquisition Corp. Warrants to purchase Class A common stock
NDACW
$960K ﹤0.01%
+98,311
New +$123K
FPI
1819
Farmland Partners
FPI
$417M
$959K ﹤0.01%
79,586
+42,186
+113% +$542K
NSC icon
1820
Norfolk Southern
NSC
$76.1B
$959K ﹤0.01%
+3,614
New +$998K
CSGS
1821
DELISTED
CSG Systems International
CSGS
$958K ﹤0.01%
+20,308
New +$925K
TUFN
1822
DELISTED
Tufin Software Technologies Ltd.
TUFN
$956K ﹤0.01%
104,891
+51,133
+95% +$480K
MDY icon
1823
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
$955K ﹤0.01%
1,945
+1,262
+185% +$623K
NAV
1824
DELISTED
Navistar International
NAV
$955K ﹤0.01%
21,459
-4,306
-17% -$191K
CNP icon
1825
CenterPoint Energy
CNP
$29B
$950K ﹤0.01%
38,745
-116,234
-75% -$2.85M
71 72
73
74 75

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.